¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ±Ô¸ð´Â 2022³â 3¾ï 3,297¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2028³â¿¡´Â 4¾ï 8,720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2028³â±îÁö CAGR 6.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¸¸¼º ¿ÏÀüÆó»ö(CTO) Ä¡·á¸¦ À§ÇÑ °æÇÇÀû °ü»óµ¿¸Æ ÁßÀç¼ú(PCI)ÀÇ »ç¿ë Áõ°¡´Â ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.
¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ´Â Àúħ½ÀÀû ½Ã¼ú¿¡ »ç¿ëµÇ´Â ÀÛÀº Á÷°æÀÇ Ä«Å×ÅÍ·Î Á¤Àǵ˴ϴÙ. Å©±â°¡ À۱⠶§¹®¿¡ ÀÎüÀÇ º¹ÀâÇÑ Ç÷°ü ½Ã½ºÅÛÀ» Ž»öÇÏ´Â µ¥ ÀÌ»óÀûÀÔ´Ï´Ù. °¡À̵å¿ÍÀ̾î Áö¿ø, ±³Ã¼, ¿øÀ§ ÇØºÎÇÐÀû ±¸Á¶¹° Á¢±Ù, º´º¯ Ⱦ´Ü, Ä¡·á¿ë »öÀüÁ¦ Àü´Þ, Á¶¿µÁ¦ ÁÖÀÔ ¹× º¹ÀâÇÑ Ç÷°ü ³» Ä¡·áÀÇ ±âŸ ÀýÂ÷¿¡ »ç¿ëµË´Ï´Ù. ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ´Â °æÇÇÀû °ü»ó µ¿¸Æ ÁßÀç¼ú(PCI)¿¡µµ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù.
¸¸¼º¿ÏÀüÆó»ö(CTO) Ä¡·á¸¦ À§ÇÑ °æÇÇÀû °ü»óµ¿¸ÆÁßÀç¼ú(PCI) »ç¿ë È®´ë, ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê
°æÇÇÀû °ü»óµ¿¸ÆÁßÀç¼ú(PCI)Àº ¸¸¼º ¿ÏÀüÆó»ö(CTO) Ä¡·á¿¡¼ °¡Àå ¾î·Á¿î ½Ã¼ú Áß ÇϳªÀ̸ç, CTO¸¦ ¼º°øÀûÀ¸·Î Àç°³Åë½Ã۴µ¥, CTOPCI´Â ¹Ì±¹ ³» ¾ÈÁ¤Çü Çù½ÉÁõ¿¡ ´ëÇÑ Àüü PCIÀÇ 4%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¶ÇÇÑ, CTO´Â Çϳª ÀÌ»óÀÇ °ü»óµ¿¸ÆÀÌ ¿ÏÀüÈ÷ ¸·Çû°Å³ª °ÅÀÇ ¸·Èù »óÅÂÀÔ´Ï´Ù. °ü»óµ¿¸Æ¿¡ ÇöóÅ©°¡ ½×ÀÌ¸é¼ ¾à 3°³¿ù°£ Áö¼ÓµÇ´Â °æ¿ì°¡ ´ëºÎºÐÀÔ´Ï´Ù. ¹Ì±¹ ±¹¸³½ÉÆóÇ÷¾×¿¬±¸¼Ò¿¡ µû¸£¸é CTO´Â Ç÷°üÁ¶¿µ¼úÀ» ¹ÞÀº ȯÀÚÀÇ ¾à 3ºÐÀÇ 1¿¡¼ ¹ß°ßµÇ¸ç, À¯·Î½ºÅÈ¿¡ µû¸£¸é 2020³â¿¡ 100¸¸ °ÇÀÇ °ü»óµ¿¸Æ ¼ºÇü¼ú°ú 138,000°ÇÀÇ ½ÉÀå ¿ìȸ¼úÀÌ ½ÃÇàµÇ¾ú½À´Ï´Ù.
Áö³ 10³â°£ ÀÌ ºÐ¾ß´Â »õ·Î¿î Á¦Ç°ÀÇ Ãâ½Ã¿Í ½ÂÀÎÀ¸·Î Å« ÁøÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. ±×·¯³ª °ü»óµ¿¸Æ ÁßÀç¼ú µµ±¸·Î »ç¿ëµÇ´Â ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ¿Í °°ÀÌ CTO¿¡ ´ëÀÀÇÏ´Â ½Ã¼ú¿¡¼ »õ·Î¿î ±â¼ú ÀåÄ¡ÀÇ Ãâ½Ã¿Í Àü·«Àû °³¼±ÀÌ ¿©ÀüÈ÷ ¸ð´ÏÅ͸µµÇ°í ÀÖ½À´Ï´Ù. ÀÌ µµ±¸´Â ºÐÁö º´º¯, ±¸ºÒ±¸ºÒÇÑ ÇØºÎÇÐÀû ±¸Á¶, °ñ´Ü À§Ä¡, °ü»óµ¿¸Æ ¼®È¸È, °¢Áø ÀÌÅ», CTO¿Í °°Àº º¹ÀâÇÑ °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¡ ´ëÇÑ Ä¡·áÀû Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù. ThermoÀÇ FineCross MG ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ´Â ±³Â÷ ´É·Â°ú °¡À̵å¿ÍÀ̾î Áö¿øÀ» ÅëÇÕÇÏ¿© ±¸ºÎ·¯Áø Ç÷°ü, CTO, ºÐÁö, ½ÉÇÑ ÇùÂø º´º¯ ¹× ¼®È¸È º´º¯À» Æ÷ÇÔÇÑ ±î´Ù·Î¿î »ç·Ê¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Ù°í Europa GroupÀº ¹àÇû´Ù, µà¾ó ·ç¸à ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ(DLMC)´Â CTO Ä¡·á¸¦ À§ÇÑ PCI¿¡¼ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾úÀ¸¸ç, DLMC´Â CTO ³» ¶Ç´Â CTO ±Ùó¿¡¼ °ü»óµ¿¸Æ ºÐÁö¸¦ º¸Á¸ÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ, ÃøºÎºÐÁö ¼±ÅÃ, Àü¹æ ÇØ¸®¿Í ÀçÁøÀÔ, º´·Ä ¹è¼± º¯°æ, ¿øÀ§ CTO ĸÀÇ ¿ªÇ༺ Çù»ó µîµµ °¡´ÉÇÕ´Ï´Ù. µû¶ó¼ CTO Ä¡·á¿¡¼ PCIÀÇ »ç¿ë ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÀå ¹Ì¼¼ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
À¯·´¿¡¼ °ø°ø ÀÇ·áºñ ÁöÃâÀÌ ±¹³» ÁöÃ⺸´Ù ºü¸¥ ¼Óµµ·Î Áõ°¡Çϰí ÀÖÁö¸¸, ÀÌ´Â ÁÖ·Î °í¼Òµæ ±¹°¡¿¡¼ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, Eurostat¿¡ µû¸£¸é 2021³â EUÀÇ ÃÑ ÀÇ·áºñ ÁöÃâÀº 1Á¶ 2,839¾ï 8,000¸¸ ´Þ·¯(1Á¶ 1,790¾ï À¯·Î)¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. EU ȸ¿ø±¹ Áß °¡Àå ¸¹Àº ÀÇ·áºñ¸¦ ÁöÃâÇÏ´Â ±¹°¡´Â µ¶ÀÏ·Î 2020³â 5,306¾ï ´Þ·¯(4,320¾ï À¯·Î), 2À§´Â ÇÁ¶û½º 3,451¾ï 4,000¸¸ ´Þ·¯(2,810¾ï À¯·Î), 3À§´Â ÀÌÅ»¸®¾Æ 1,965¾ï 2,000¸¸ ´Þ·¯(1,600¾ï À¯·Î)·Î ³ªÅ¸³µ½À´Ï´Ù. ¹ÌÈ 1,600¾ï ´Þ·¯(1,600¾ï À¯·Î), 4À§´Â ½ºÆäÀÎÀ¸·Î 1,473¾ï 9,000¸¸ ´Þ·¯(1,200¾ï À¯·Î)ÀÔ´Ï´Ù. ¶ÇÇÑ À¯·´À§¿øÈ¸ÀÇ EU4Health ÇÁ·Î±×·¥, Â÷¼¼´ë Àç»ý ±â±Ý ¹× Horizon Europe ¿¬±¸ ±â±ÝÀº ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀ» ÇØ°áÇÏ°í ´õ ³ªÀº ½ÉÇ÷°ü °Ç°À» À§ÇÑ EU Çൿ °èȹ¿¡ ¸í½ÃµÈ ¿¹¹æ Á¶Ä¡¸¦ ½ÃÇàÇÏ¿© ½Ã¹ÎÀÇ ½ÉÇ÷°ü °Ç°À» °³¼±ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ °èȹÀº ¿¹¹æ ¹× Á¶±â ¹ß°ß¿¡¼ Ä¡·á ¹× Ä¡·á Á¢±Ù¼º, »îÀÇ Áú ¹× ±â´É »óÅ¿¡ À̸£±â±îÁö ȯÀÚÀÇ Àüü ¿©Á¤À» ´Ù·ç°í ÀÖÀ¸¸ç, ¸ðµç ´Ü°è¿¡¼ µðÁöÅÐÈ¿Í Çõ½ÅÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â Á¡À» °í·ÁÇϰí ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ½ÉÀå ¹Ì¼¼ Ä«Å×ÅÍ ½ÃÀå¿¡ ÃæºÐÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾Æ¸Þ¸®Ä« Áö¿ª HEARTS ÀÌ´Ï¼ÅÆ¼ºê´Â ÇöÁö ÀÌÇØ°ü°èÀÚÀÇ Âü¿©¿Í ¹ü¹Ìº¸°Ç±â±¸(PAHO)ÀÇ ±â¼ú Çù·ÂÀ¸·Î º¸°ÇºÎ°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÌ Áö¿ª 22°³±¹, 1,400°³ ÀÌ»óÀÇ º¸°Ç¼Ò¿¡¼ ½ÃÇàµÇ°í ÀÖÀ¸¸ç, 2025³â±îÁö HEARTS´Â ºÏ¹Ì¿Í ³²¹ÌÀÇ 1Â÷ÀÇ·á¿¡¼ °íÇ÷¾Ð, ´ç´¢º´, ÀÌ»óÁöÁúÇ÷ÁõÀ» Æ÷ÇÔÇÑ ½ÉÇ÷°ü À§Çè °ü¸®ÀÇ ¸ðµ¨ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå¿¡¼ ½ÉÀ庴Àº 463¾ï ´Þ·¯(È£ÁÖ, Áß±¹ º»Åä, È«Äá, ÀϺ», ½Ì°¡Æ÷¸£, Çѱ¹, ´ë¸¸, ű¹¿¡¼ ÃßÁ¤)ÀÇ ºñ¿ëÀ» ¹ß»ý½Ã۰í ÀÖÀ¸¸ç, 2022³â Polos One Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹® 'Cost analysis of treating cardiovascular diseases in a super-specialty hospital'¿¡ µû¸£¸é, ¸ðµç ½ÉÇ÷°ü ÁúȯÀ» Ä¡·áÇÏ´Â µ¥ µå´Â ȯÀÚ 1ÀÎ´ç ºñ¿ëÀº 3,842´Þ·¯(247,822 ·çÇÇ)·Î °è»êµÆ½À´Ï´Ù. ·ù¸¶Æ¼½º¼º ½ÉÀå ÁúȯÀÇ Ä¡·áºñ°¡ ¸ðµç ½ÉÇ÷°ü Áúȯ Áß °¡Àå ³ô¾Ò°í, ½É±ÙÁõ, ±âŸ ½ÉÇ÷°ü ÁúȯÀÌ ±× µÚ¸¦ À̾ú½À´Ï´Ù. µû¶ó¼ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ½ÉÀå °Ç°¿¡ ´ëÇÑ Á¤ºÎ ÁÖµµÀÇ ³ë·ÂÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÉÀå ¹Ì¼¼ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀå ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÎ¹®º° ºÐ¼®
ÀλçÀÌÆ®¿¡ ±â¹ÝÇÑ ÅëÂû·Â
ÀλçÀÌÆ®¿¡ µû¸£¸é, ½ÉÀå ¹Ì¼¼ Ä«Å×ÅÍ ½ÃÀåÀº ÀÏ¹Ý ¸»ÃÊ Ç÷°ü°ú °ü»ó µ¿¸ÆÀ¸·Î ³ª´¹´Ï´Ù. °ü»óµ¿¸Æ ºÎ¹®Àº 2022³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡¼ ´õ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °ü»óµ¿¸Æ ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä´Â Çù½ÉÁõ°ú °°Àº °ü»óµ¿¸Æ ÁúȯÀÇ ÀÌȯÀ² Áõ°¡¿Í ½ÉÀå µ¹¿¬»ç »ç·Ê Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚ ±â¹ÝÀÇ ÀλçÀÌÆ®
ÃÖÁ¾ »ç¿ëÀÚ¿¡ µû¶ó ½ÉÀå ¹Ì¼¼ Ä«Å×ÅÍ ½ÃÀåÀº º´¿ø, Àü¹® Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)·Î ºÐ·ùµË´Ï´Ù. º´¿ø ºÎ¹®Àº 2022³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. º´¿ø ¼ö Áõ°¡, »óȯ Á¤Ã¥ÀÇ °³¼±, ½ÉÇ÷°ü ÁúȯÀÇ ±Þ°ÝÇÑ Áõ°¡°¡ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÊ¿¡ µû¶ó º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡¼ ´õ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÉÀå¿ë ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå¿¡ ´ëÇÑ º¸°í¼¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ ÁÖ¿ä 1Â÷ ¹× 2Â÷ Á¤º¸¿¡´Â È£ÁÖ º¸°Ç º¹Áö ¿¬±¸¼Ò, ±¹¸³ º¸°Ç¿ø µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ÁÖ¿ä ¿äÁ¡
Á¦3Àå Á¶»ç ¹æ¹ý
- Á¶»ç ¹üÀ§
- 2Â÷ Á¶»ç
- 1Â÷ Á¶»ç
Á¦4Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ½ÃÀå ±¸µµ
- PEST ºÐ¼®
- ºÏ¹ÌÀÇ PEST ºÐ¼®
- À¯·´ÀÇ PEST ºÐ¼®
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ PEST ºÐ¼®
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ PEST ºÐ¼®
- Áß³²¹ÌÀÇ PEST ºÐ¼®
- Àü¹®°¡ÀÇ °ßÇØ
Á¦5Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ÇâÈÄ µ¿Çâ
- ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
Á¦6Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ¼¼°è ºÐ¼®
- ¼¼°èÀÇ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ¸ÅÃâ°ú ¿¹Ãø ºÐ¼®
- ¼¼°èÀÇ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : Áö¿ªº° ¿¹Ãø°ú ºÐ¼®
- ¼¼°èÀÇ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
- Medtronic Plc.
- Boston Scientific Corp
Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : 2028³â±îÁö ¸ÅÃâ°ú ¿¹Ãø-ÀûÀÀÁõº°
Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ºÐ¼®-ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- Àü¹® Ŭ¸®´Ð
Á¦9Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : 2028³â±îÁö ¸ÅÃâ°ú ¿¹Ãø - Áö¿ªº° ºÐ¼®
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áß³²¹Ì
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ±âŸ Áß³²¹Ì
Á¦10Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áß³²¹Ì
Á¦11Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ¾÷°è »óȲ
Á¦12Àå ±â¾÷ °³¿ä
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- OrbusNeich Medical Group Holdings Ltd
- Asahi Intecc USA Inc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Tokai Medical Products Inc
- Integer Holdings Corp
Á¦13Àå ºÎ·Ï
LSH 23.07.19
The cardiac microcatheter market size was valued at US$ 332.97 million in 2022 and is projected to reach US$ 487.20 million by 2028; it is expected to grow with a CAGR of 6.8% from 2023 to 2028.
An increasing prevalence of cardiovascular diseases and the growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO) are among the factors contributing to the cardiac microcatheter market growth.
Microcatheter is defined as a small diameter catheter that is used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body. It is used for guidewire support, exchanges, to access distal anatomy, cross lesions, deliver therapeutic embolic, inject contrast media, and perform other procedures in complex endovascular procedures. Microcatheters are also commonly used in percutaneous coronary intervention (PCI).
Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO), Increase in Healthcare Expenditures and Government Initiatives
Percutaneous coronary intervention (PCI) is one of the most difficult procedures for treating of chronic total occlusions (CTO), resulting in successful recanalization of CTO. CTOPCIs represent 4% of all PCIs for stable angina in the US. Further, CTO is complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. As per the National Heart, Lung, and Blood Institute, CTOs are found in approximately one-third of patients undergoing angiography. According to Eurostat, 1 million transluminal coronary angioplasty surgeries and 138,000 cardiac bypass surgeries were performed in 2020.
Significant progress has been made in this area over the past decade, given the novel product launches and approvals. However, the launch of new technical devices and strategic refinements are still being monitored in the procedures to combat CTOs as the microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and CTO. Terumo's FineCross MG microcatheter integrates cross ability and guidewire support for treating challenging cases including tortuous vessels, CTOs, bifurcations, as well as severely stenosed and calcified lesions. According to Europa Group, dual lumen microcatheters (DLMCs) have become indispensable tools in the context of PCI for the treatment of CTO. DLMC allows the preservation and management of bifurcated coronary branches within or near the CTO body. It also enables the usage of collateral selection, antegrade dissection and re-entry, modified parallel wiring, and retrograde negotiation of the distal CTO cap. Therefore, the growing usage of PCIs for treating CTO is catalysing the cardiac microcatheter market growth.
In Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. Eurostat stated that the EU's total government expenditure on healthcare in 2021 was ~US$ 1,283.98 billion (€ 1,179 billion), or 8.1% of the region's GDP. Germany recorded the highest healthcare expenditure among the EU member states, with US$ 530.60 billion (€ 432 billion) in 2020. France recorded the second-highest healthcare expenditure [US$ 345.14 billion (€ 281 billion)], followed by Italy [US$ 196.52 billion (€ 160 billion)] and Spain [US$ 147.39 billion (€ 120 billion)]. Further, the European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. The increasing healthcare expenditure in developed and developing economies are expected to create ample opportunities in the cardiac microcatheter market.
The Initiative HEARTS in the Americas is led by the Ministries of Health with the participation of local stakeholders and the technical cooperation of the Pan American Health Organization (PAHO). The Initiative is being implemented in more than 1,400 health centers in 22 countries across the region. By 2025, HEARTS will be the model for cardiovascular risk management, including hypertension, diabetes, and dyslipidemia, in primary health care in the Americas. Moreover, heart disease costs the Asia Pacific markets US$ 46.3 billion (estimated across Australia, Mainland China, Hong Kong, Japan, Singapore, South Korea, Taiwan, and Thailand). According to the article "Cost analysis of treating cardiovascular diseases in a super-specialty hospital," published in 2022 in Polos One, per patient cost of treating any cardiovascular disorders was computed to be US$ 3,842 (INR 247,822). The cost of treating rheumatic heart disease was the highest among all cardiovascular disorders, followed by cardiomyopathy and other cardiovascular disorders. Therefore, increasing healthcare spending and government-led initiatives regarding heart health are expected to provide an opportunity for the cardiac microcatheter market growth in the coming years.
Segmental Analysis
Insight-Based Insights
Based on insight, the cardiac microcatheter market is bifurcated into general peripheral vascular and coronary. The coronary segment held a larger market share in 2022 and is anticipated to register a higher CAGR in the market during the forecast period. The demand for coronary microcatheter is increasing due to the rising incidences of coronary artery diseases like angina pectoris and increasing cases of abrupt cardiac death.
End User-Based Insights
Based on end user, the cardiac microcatheter market is segregated as hospitals, specialty clinics, ambulatory surgical centers. The hospitals segment held the largest market share in 2022. The hospitals segment is anticipated to register the higher CAGR in the market during the forecast period due to the increasing number of hospitals, improvements in reimbursement policies, and surging incidences of cardiovascular diseases are expected to drive the cardiac microcatheter market.
A few of the major primary and secondary sources referred to while preparing the report on the cardiac microcatheter market are the Australian Institute of Health and Welfare and National Institute of Health, among others.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global cardiac microcatheters market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cardiac microcatheters market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook in regional market coupled with the factors driving the market, as well as those hindering it.
- Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Cardiac Microcatheter Market - by Indication
- 1.3.2 Global Cardiac Microcatheter Market - by End User
- 1.3.3 Global Cardiac Microcatheter Market - by Geography
2. Cardiac Microcatheter Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Cardiac Microcatheter Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
- 4.3 Experts' Opinion
5. Cardiac Microcatheter Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Cardiovascular Diseases
- 5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
- 5.2 Market Restraints
- 5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheter
- 5.3 Market Opportunity
- 5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
- 5.4 Future Trends
- 5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter
- 5.5 Impact Analysis of Drivers and Restraints
6. Cardiac Microcatheter Market - Global Analysis
- 6.1 Global Cardiac Microcatheter Market Revenue Forecast and Analysis
- 6.2 Global Cardiac Microcatheter Market, by Geography - Forecast and Analysis
- 6.2.1 Market Positioning of Key Players in Global Cardiac Microcatheter Market
- 6.2.1.1 Medtronic Plc.
- 6.2.1.2 Boston Scientific Corp
7. Global Cardiac Microcatheter Market - Revenue and Forecast to 2028 - by Indication
- 7.1 Overview
- 7.2 Coronary
- 7.2.1 Overview
- 7.2.2 Coronary: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3 General Peripheral Vascular
- 7.3.1 Overview
- 7.3.2 General Peripheral Vascular: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
8. Global Cardiac Microcatheter Market Analysis - by End User
- 8.1 Overview
- 8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Overview
- 8.3.2 Ambulatory Surgical Centers: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
9. Cardiac Microcatheter Market - Revenue and Forecast to 2028 - Geographic Analysis
- 9.1 North America: Cardiac Microcatheter Market
- 9.1.1 Overview
- 9.1.2 North America: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 North America: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.4 North America: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.5 North America: Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
- 9.1.5.1 US: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.1.1 Overview
- 9.1.5.1.2 US: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.1.3 US: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.5.1.4 US: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.5.2 Canada: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.2.1 Overview
- 9.1.5.2.2 Canada: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.2.3 Canada: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.5.2.4 Canada: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.5.3 Mexico: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.3.1 Overview
- 9.1.5.3.2 Mexico: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.3.3 Mexico: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.5.3.4 Mexico: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2 Europe: Cardiac Microcatheter Market
- 9.2.1 Overview
- 9.2.2 Europe: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.3 Europe: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.4 Europe: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5 Europe: Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
- 9.2.5.1 UK: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.1.1 Overview
- 9.2.5.1.2 UK: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.1.3 UK: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.1.4 UK: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5.2 Germany: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.2.1 Overview
- 9.2.5.2.2 Germany: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.2.3 Germany: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.2.4 Germany: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5.3 France: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.3.1 Overview
- 9.2.5.3.2 France: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.3.3 France: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.3.4 France: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5.4 Italy: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.4.1 Overview
- 9.2.5.4.2 Italy: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.4.3 Italy: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.4.4 Italy: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5.5 Spain: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.5.1 Overview
- 9.2.5.5.2 Spain: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.5.3 Spain: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.5.4 Spain: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.2.5.6 Rest of Europe: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.6.1 Overview
- 9.2.5.6.2 Rest of Europe: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.5.6.3 Rest of Europe: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.2.5.6.4 Rest of Europe: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3 Asia Pacific: Cardiac Microcatheter Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.3 Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4 Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.1 China: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.1.1 Overview
- 9.3.4.1.2 China Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.1.3 China Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4.1.4 China Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.2 Japan: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.2.1 Overview
- 9.3.4.2.2 Japan Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.2.3 Japan Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4.2.4 Japan Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.3 India: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.3.1 Overview
- 9.3.4.3.2 India Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.3.3 India Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4.3.4 India Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.4 Australia: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.4.1 Overview
- 9.3.4.4.2 Australia Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.4.3 Australia Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4.4.4 Australia Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.5 South Korea: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.5.1 Overview
- 9.3.4.5.2 South Korea Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.5.3 South Korea Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.3.4.5.4 South Korea Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.3.4.6 Rest of Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.6.1 Overview
- 9.3.4.6.2 Rest of Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.6.3 Rest of Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
- 9.3.4.6.4 Rest of Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Middle East & Africa Cardiac Microcatheter Market
- 9.4.1 Overview
- 9.4.2 Middle East & Africa: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.3 Middle East & Africa: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.4.4 Middle East & Africa: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.4.5 Middle East & Africa: Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
- 9.4.5.1 Saudi Arabia: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.1.1 Overview
- 9.4.5.1.2 Saudi Arabia: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.1.3 Saudi Arabia: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.4.5.1.4 Saudi Arabia: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.4.5.2 South Africa: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.2.1 Overview
- 9.4.5.2.2 South Africa: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.2.3 South Africa: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.4.5.2.4 South Africa: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.4.5.3 UAE: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.3.1 Overview
- 9.4.5.3.2 UAE: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.3.3 UAE: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.4.5.3.4 UAE: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.4.5.4 Rest of Middle East & Africa: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.4.1 Overview
- 9.4.5.4.2 Rest of Middle East & Africa: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.4.3 Rest of Middle East & Africa: Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.4.5.4.4 Rest of Middle East & Africa: Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.5 South & Central America Cardiac Microcatheter Market
- 9.5.1 Overview
- 9.5.2 South & Central America Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.3 South & Central America Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.5.4 South & Central America Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.5.4.1 Argentina: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.1.1 Overview
- 9.5.4.1.2 Argentina Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.1.3 Argentina Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.5.4.1.4 Argentina Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.5.4.2 Brazil: Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.2.1 Overview
- 9.5.4.2.2 Brazil Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.2.3 Brazil Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.5.4.2.4 Brazil Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.5.4.3 Rest of South & Central America Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.3.1 Overview
- 9.5.4.3.2 Rest of South & Central America Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.3.3 Rest of South & Central America Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
- 9.5.4.3.4 Rest of South & Central America Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10. Impact Of COVID-19 Pandemic on Cardiac Microcatheter Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 10.2 Europe: Impact Assessment of COVID-19 Pandemic
- 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
- 10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
- 10.5 South & Central America: Impact Assessment of COVID-19 Pandemic
11. Cardiac Microcatheter Market - Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
12. Company Profiles
- 12.1 Boston Scientific Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Teleflex Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 OrbusNeich Medical Group Holdings Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Asahi Intecc USA Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Merit Medical Systems Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Nipro Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Terumo Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Tokai Medical Products Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Integer Holdings Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms